How much does health insurance reimburse bedaquiline? Will the price decrease?

Recently, the anti-tuberculosis drug bedaquiline (Bedaquiline) has been officially included in China's national medical insurance directory. This news is undoubtedly great news for many patients with multidrug-resistant tuberculosis (MDR-TB). As a key drug in the treatment of drug-resistant pulmonary tuberculosis, bedaquiline has attracted much attention due to its remarkable efficacy, especially for patients who have developed resistance to traditional anti-tuberculosis drugs (such as isoniazid and rifampicin). It has brought new hope for treatment.

However, the high cost of bedaquiline treatment once discouraged patients. In the domestic market, the common specification of this drug is 100mg*24 tablets, with the price range of each box ranging from RMB 6,000 to RMB 7,000. Considering that a complete course of treatment usually lasts 24 weeks, that is, 6 months, the total cost often reaches tens of thousands of yuan, which is undoubtedly a heavy financial burden for many patient families.

Fortunately, with the inclusion of bedaquiline in the medical insurance catalog, patients' financial pressure has been effectively alleviated. The implementation of the medical insurance policy means that patients can enjoy a certain percentage of reimbursement, thus significantly reducing actual expenditures. The specific reimbursement ratio and amount vary by region. It is recommended that patients consult the local medical insurance department or hospital pharmacy in a timely manner to obtain the most accurate reimbursement information.

The expansion of medical insurance coverage not only reduces patients' financial burden, but also improves their treatment compliance. For multidrug-resistant tuberculosis, a global health challenge, drug availability is directly related to treatment effectiveness and the risk of disease transmission. Therefore, the inclusion of bedaquiline in medical insurance will undoubtedly provide more patients with the opportunity to receive standardized treatment, which will help reduce the spread of tuberculosis and improve public health.

Of course, even with the help of medical insurance reimbursement, patients still need to pay close attention to various monitoring indicators during the treatment process. For example, regular electrocardiograms and liver function tests are important measures to ensure medication safety and manage potential side effects. Standardized treatment under the guidance of a doctor, combined with the support of medical insurance policies, is believed to be able to significantly improve the patient's treatment effect and quality of life.